Randomised Controlled Trial Of Hepatitis B Vaccine Completion In Injecting Drug Users
Funder
National Health and Medical Research Council
Funding Amount
$463,355.00
Summary
This randomised trial will examine strategies to increase hepatitis B vaccination in drug users by comparing 1) usual clinical care; 2) enhanced outreach; and 3) financial incentive payments and assessing the proportion in each group who a) complete all 3 doses and b) develop immunity. Results will provide policy-makers and clinicians with important data on effectiveness, including cost effectiveness, and will help scientists and affected communities prepare for clinical trials of new vaccines.
Is Male Circumcision An Acceptable And Feasible Intervention To Reduce HIV Transmission In Papua New Guinea
Funder
National Health and Medical Research Council
Funding Amount
$624,913.00
Summary
In PNG, Australia's nearest neighbour, 76 000 people live with HIV with predictions of up to 500 000 by 2025. African studies show 60% reduction in HIV if men are circumcised. Because relatively few men in PNG are circumcised, promoting circumcision may save thousands of lives. This study examines an NHMRC research priority area in Global Health by analysing social, cultural and religious aspects of circumcision. The study will assess if circumcision is an acceptable way to reduce HIV in PNG.
An Investigation Of The Relationship Between The Pharmaceutical Industry, Medical Profession And Medical Practitioners
Funder
National Health and Medical Research Council
Funding Amount
$186,449.00
Summary
In recent years there has been a rapid expansion in the number and range of interactions between the pharmaceutical industry and the medical profession. While this has the potential to advance research, education and health care, there are risks that such interactions may inappropriately serve commercial objectives and ultimately compromise the best interests of patients and society in general. Most major medical and pharmaceutical organisations have released guidelines of policy statements on t ....In recent years there has been a rapid expansion in the number and range of interactions between the pharmaceutical industry and the medical profession. While this has the potential to advance research, education and health care, there are risks that such interactions may inappropriately serve commercial objectives and ultimately compromise the best interests of patients and society in general. Most major medical and pharmaceutical organisations have released guidelines of policy statements on the relationship between the medical profession and the pharmaceutical industry. To date most debate has taken the form of personal observations or professional opinion , and there has been little objective research into medical industry interactions. This project aims to examine the relationship between the pharmaceutical industry, the medical profession and the medical practitioners. Specifically, the aim of this project is to establish whether this relationship as it currently exists, and as stated in guidelines from professional bodies, is appropriate in terms of justifiable ethical standards, empirical research and social perspectives. The results of this research will enable assessment of current guidelines and the development of further guidelines and regular process where appropriate.Read moreRead less